Fundraising Fox
Foldax
Salt Lake City, US · Founded 2013 · 38 employees on LinkedIn · 11 known investors
Find your way into Foldax
Sign up to see every warm intro you have to Foldax
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Foldax team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design. The company targets patients who require valve replacement, particularly young women with rheumatic disease in developing countries and aging patients in developed markets facing multiple surgeries.
Founders & leadership
FM
Frank MaguireNamed on SEC filing
Board
KC
Ken CharhutBoard directorBoard Member; Executive Chairman of the Board, Foldax, Inc. at MemorialCare Innovation Fund
GW
George WallaceBoard director
MG
Morteza GharibBoard director
MG
Mory GharibBoard director
Investors · 11
Angel Physicians Fundlisted by Angel Physicians Fund
How we know: Angel Physicians Fund's portfolio page · a partner's Signal profile · medicaldevice-network.com · Not right? Tell us
Kairos Venture Investments, Llclisted by Kairos Venture Investments, LlcBeverly Hills · $150K – $20M
How we know: Kairos Venture Investments, Llc's portfolio page · Not right? Tell us
MemorialCare Innovation Fundlisted by MemorialCare Innovation FundLong Beach
How we know: MemorialCare Innovation Fund's portfolio page · funding news · Not right? Tell us
BioStar CapitalreportedCharlevoix · $250K – $3M
How we know: medicaldevice-network.com · Not right? Tell us
BioStar VenturesreportedPetoskey
How we know: funding news · Not right? Tell us
Kairos Venture PartnersinferredBeverly Hills
How we know: board seat on SEC Form D · Not right? Tell us
SUMMATION HEALTH VENTURESreportedLong Beach
How we know: funding news · Not right? Tell us
Also in the syndicate · 4
CaltechKairos VenturesMemorial Care Innovation Fund (MCIF)leadSayan Bioventures
Funding
SEC filings, press & company announcements$43.7M disclosed across 10 of 11 rounds · 2014–2023
- $20MSeries DJun 2020 · 2 sources
Memorial Care Innovation Fund (MCIF) (lead), Angel Physicians Fund (APF), BioStar Capital, Caltech, Kairos Ventures, Sayan Bioventures
Source ↗
▶$7MraisedNov 2023 · 10 investors · BiotechnologyRule 506(b)
▶$7MraisedNov 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Scott HuennekensDirector
- Ken CharhutDirector
- Jim DemetriadesDirector
- Scott RichlandDirector
- George WallaceDirector
- Greg CasciaroExecutive Officer, Director
- Brant HeiseDirector
- Amount sold
- $7M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MofferedJan 2022 · OtherRule 506(b)
▶$15MofferedJan 2022 · Other
Rule 506(b)Officers, directors & promoters on the filing
- James DemetriadesDirector
- George WallaceDirector
- Scott HuennekensDirector
- Renee MasiDirector
- Brant HeiseDirector
- Morteza GharibDirector
- Kenneth CharhutDirector
- Offering amount
- $15M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.3MraisedDec 2018 · 15 investors · Other TechnologyRule 506(b)
▶$10.3MraisedDec 2018 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jim DemetriadesDirector
- George WallaceDirector
- Ken CharhutDirector
- Frank MaguireExecutive Officer, Director
- Mory GharibDirector
- Renee MasiDirector
- Offering amount
- $10.3M
- Amount sold
- $10.3M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KraisedMay 2017 · 1 investors · OtherRule 506(b)
▶$300KraisedMay 2017 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- George WallaceDirector
- James DemetriadesDirector
- Morteza GharibDirector
- Frank MaguireExecutive Officer, Director
- Ken CharhutDirector
- Offering amount
- $9M
- Amount sold
- $300K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.1MraisedJul 2016 · 9 investors · OtherRule 506(b)
▶$3.1MraisedJul 2016 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Frank MaguireExecutive Officer, Director
- Demetriades JamesDirector
- Ken CharhutDirector
- Morteza GharibDirector
- George WallaceDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$2.5MraisedSep 2015 · 1 investors · OtherRule 506(b)
▶$2.5MraisedSep 2015 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Morteza GharibDirector
- Frank MaguireExecutive Officer, Director
- Ken CharhutDirector
- George WallaceDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$350KraisedJun 2015 · 2 investors · Other TechnologyRule 506(b)
▶$350KraisedJun 2015 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank MaguireExecutive Officer, Director
- George WallaceDirector
- Morteza GharibDirector
- Ken CharhutDirector
- Offering amount
- $1.5M
- Amount sold
- $350K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$50KraisedAug 2014 · 1 investors · OtherRule 506(b)
▶$50KraisedAug 2014 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ken CharhutDirector
- George WallaceDirector
- Mory GharibDirector
- Frank MaguireExecutive Officer, Director
- Offering amount
- $4.8M
- Amount sold
- $50K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Edwards LifesciencesEdwards Lifesciences develops innovative medical technologies for treating cardiovascular disease, focusing on structural heart interventions. The company serves patients and healthcare providers globally through partnerships with clinicians and healthcare stakeholders.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
CardiovalveCardiovalve develops a transcatheter valve replacement system designed to fit both mitral and tricuspid anatomies via transfemoral delivery, avoiding open heart surgery. The device targets structural heart disease and is currently restricted to research use.
Companies working in the same space as Foldax.
In the news
Frequently asked questions
- What does Foldax do?
- Foldax develops heart valve replacement technology leveraging polymer expertise and biologic design. The company targets patients who require valve replacement, particularly young women with rheumatic disease in developing countries and aging patients in developed markets facing multiple surgeries.
- Who are Foldax's investors?
- Foldax's investors include Angel Physicians Fund, Kairos Venture Investments, Llc, MemorialCare Innovation Fund, BioStar Capital, BioStar Ventures, Kairos Venture Partners, SUMMATION HEALTH VENTURES.
- How much funding has Foldax raised?
- Foldax has disclosed $43.7M raised across 10 of its 11 known rounds.
- Where is Foldax headquartered?
- Foldax is headquartered in Salt Lake City, US.